DOCMF - Dr. Martens plc

Other OTC - Other OTC Delayed price. Currency in USD

Dr. Martens plc

28 Jamestown Road
London NW1 7BY
United Kingdom
44 12 1415 7047

Sector(s)Consumer Cyclical
IndustryFootwear & Accessories
Full-time employees2,229

Key executives

NameTitlePayExercisedYear born
Mr. Kenneth WilsonCEO & Director926.12kN/A1967
Mr. Jon W. MortimoreCFO & Director602.59kN/AN/A
Mr. Geert PeetersChief Operating OfficerN/AN/A1966
Mr. Ronald GarricksChief Information OfficerN/AN/AN/A
Ms. Emily ReichwaldGen. Counsel & Company Sec.N/AN/AN/A
Ms. Meg JohnsonChief Marketing OfficerN/AN/AN/A
Ms. Sue GannonChief HR OfficerN/AN/AN/A
Mr. Lorenzo MorettiPres of EMEAN/AN/AN/A
Mr. Sean O'NeillChief Digital OfficerN/AN/AN/A
Mr. Derek ChanPres of APACN/AN/AN/A
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Dr. Martens plc designs, develops, procures, markets, sells, and distributes footwear in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. Its product segments include originals, fusion, kids, and casual, as well as accessories. The company offers its products under the Dr. Martens brand name. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.

Corporate governance

Dr. Martens plc’s ISS governance QualityScore as of 30 May 2023 is 5. The pillar scores are Audit: 5; Board: 5; Shareholder rights: 1; Compensation: 6.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.